Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.05 EUR | -.--% | -2.05% | +2.50% |
24/04 | Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... | |
24/04 | CVC Said Mulling Options for Majority Stake in Recordati | MT |
Chart calendar Recordati
Upcoming events on Recordati
Past events on Recordati
12/03/2024 | Barclays Global Healthcare Conference |
27/02/2024 | UBS European Healthcare Conference |
22/02/2024 08:30 pm | Q4 2023 Earnings Call |
22/02/2024 05:15 pm | Q4 2023 Earnings Release |
10/01/2024 | J.P. Morgan Healthcare Conference |
20/11/2023 | Ex-dividend day for dividende intermédiaire |
14/11/2023 | Jefferies London Healthcare Conference |
09/11/2023 | Roadshow - Deutsche Bank |
08/11/2023 | Roadshow - Jefferies |
07/11/2023 08:30 pm | Q3 2023 Earnings Call |
07/11/2023 05:03 pm | Q3 2023 Earnings Release |
28/07/2023 07:30 pm | Q2 2023 Earnings Call |
28/07/2023 04:13 pm | Q2 2023 Earnings Release |
22/05/2023 | Final dividend |
11/05/2023 07:30 pm | Q1 2023 Earnings Call |
11/05/2023 05:18 pm | Q1 2023 Earnings Release |
21/04/2023 12:30 pm | Annual General Meeting |
21/02/2023 08:30 pm | FY 2022 Earnings Call |
21/02/2023 | FY 2022 Earnings Release |
21/11/2022 | Ex-dividend day for dividende intermédiaire |
Past dividends on Recordati
20/11/2023 | Interim Payment 0.57 EUR |
22/05/2023 | Final Payment 0.6 EUR |
21/11/2022 | Interim Payment 0.55 EUR |
23/05/2022 | Final Payment 0.57 EUR |
22/11/2021 | Interim Payment 0.53 EUR |
24/05/2021 | Final Payment 0.55 EUR |
23/11/2020 | Interim Payment 0.5 EUR |
18/05/2020 | Final Payment 0.52 EUR |
18/11/2019 | Interim Payment 0.48 EUR |
23/04/2019 | Final Payment 0.47 EUR |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 1 482 1 472 0.67% | 1 449 1 468 -1.29% | 1 580 1 579 0.07% | 1 853 1 852 0.06% | 2 082 2 083 -0.02% | 2 298 |
EBITDA Million EUR | Released Forecast Spread | 544 544 0.06% | 569 579 -1.6% | 602 603 -0.12% | 673 659 2.14% | 770 769 0.07% | 846 |
EBIT Million EUR | Released Forecast Spread | 465 468 -0.52% | 469 483 -2.95% | 490 507 -3.36% | 437 496 -11.76% | 558 597 -6.55% | 682 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 444 446 -0.38% | 456 463 -1.49% | 463 477 -2.86% | 401 410 -2.01% | 491 495 -0.88% | 586 |
Net income Million EUR | Released Forecast Spread | 369 332 10.97% | 355 372 -4.58% | 386 405 -4.76% | 312 367 -14.97% | 389 399 -2.56% | 477 |
EPS EUR | Released Forecast Spread | 1,76 1,59 10.94% | 1,70 1,75 -2.94% | 1,85 1,91 -3.54% | 1,49 1,59 -6.07% | 1,86 1,87 -0.39% | 2,24 |
Announcement Date | 14/02/20 | 22/02/21 | 24/02/22 | 21/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 760 780 -2.48% | 771 764 0.88% | 424 421 0.58% | 419 412 1.78% | 473 449 5.26% | 892 865 3.21% | 485 450 7.7% | 476 474 0.4% | 551 551 -0.02% | 493 494 -0.26% | 1 044 1 046 -0.12% | 512 512 0.01% | 526 530 -0.77% | |
EBITDA Million EUR | Released Forecast Spread | 311 306 1.68% | 301 296 1.55% | 154 154 -0.05% | 163 155 5.47% | 172 169 1.76% | 335 333 0.7% | 181 162 11.97% | 157 152 3.26% | 221 206 7.21% | 185 177 5.04% | 406 386 5.36% | 189 184 2.88% | 174 177 -1.57% | 242 |
EBIT Million EUR | Released Forecast Spread | 262 261 0.27% | 250 249 0.5% | 117 129 -9.12% | 131 127 3.74% | 101 131 -23.08% | 232 271 -14.21% | 124 108 14.74% | 81,4 115 -28.99% | 173 162 6.5% | 166 140 17.97% | 338 329 2.67% | 101 146 -31.03% | 119 118 1.1% | |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 254 252 0.86% | 236 235 0.06% | 113 123 -8.55% | 124 119 4.38% | 69,8 99,3 -29.66% | 194 219 -11.29% | 116 91,0 27% | 91,7 88,9 3.14% | 160 145 10.38% | 129 115 12.23% | 289 276 4.83% | 101 113 -10.48% | 101 93,8 8% | |
Net income Million EUR | Released Forecast Spread | 197 195 1.1% | 207 195 5.99% | 89,6 99,6 -10.03% | 96,7 91,5 5.7% | 54,7 76,8 -28.75% | 151 170 -11.04% | 90,1 74,2 21.37% | 70,8 87,7 -19.22% | 124 113 10.18% | 104 89,3 16.02% | 228 215 5.84% | 76,9 88,9 -13.5% | 84,7 70,3 20.54% | 132 |
EPS EUR | Released Forecast Spread | 0,94 0,94 0.21% | 0,99 | 0,43 0,52 -18.02% | 0,46 0,50 -6.67% | 0,26 0,42 -37.62% | 0,43 0,34 26.76% | 0,34 0,35 -1.74% | 0,59 0,60 -0.34% | 0,50 0,41 20.73% | 0,37 0,45 -18.22% | 0,34 | 0,63 | ||
Announcement Date | 30/07/20 | 29/07/21 | 24/02/22 | 10/05/22 | 28/07/22 | 28/07/22 | 08/11/22 | 21/02/23 | 11/05/23 | 28/07/23 | 28/07/23 | 07/11/23 | 22/02/24 | - |
Past sector events for Recordati
Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
Today | AMGEN INC.: Q1 2024 Earnings Release |
02/05/2024 01:35 am | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
02/05/2024 01:35 am | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
01/05/2024 04:15 pm | PFIZER, INC.: Q1 2024 Earnings Release |
01/05/2024 12:30 pm | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
01/05/2024 11:30 am | GSK PLC: Q1 2024 Earnings Release |
01/05/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- REC Stock
- Calendar Recordati